Serotonin-7 receptors and Alcohol-seeking Behaviors
5-羟色胺-7 受体和饮酒行为
基本信息
- 批准号:10659697
- 负责人:
- 金额:$ 49.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAgonistAlcohol dependenceAlcoholismAlcoholsAlzheimer&aposs DiseaseAnxietyBehaviorBehavior ControlChronicCognitiveCuesDataDevelopmentDorsalDrug AddictionDrug ControlsDrug Withdrawal SymptomsEnvironmentExposure toGoalsHumanIncubatedKnowledgeLaboratoriesMeasuresMediatingMental DepressionMicrodialysisModelingNatureNucleus AccumbensPharmaceutical PreparationsPlayPrecipitating FactorsRecoveryRecurrenceRegulationRelapseResearchRodentRoleSerotoninSiteSystemTechniquesTestingTherapeuticTimeViral VectorWestern Blottingalcohol abuse therapyalcohol cravingalcohol seeking behaviorantagonistattenuationcravingdrug cravingdrug rewarddrug seeking behaviorexperimental studyextracellularknock-downneural circuitneurochemistryoverexpressionpainful neuropathypharmacologicprolonged abstinencereceptorreceptor expressionrelapse preventionresponseserotonin 7 receptortherapeutic target
项目摘要
ABSTRACT:
Drug addiction can be characterized as a chronic reoccurring illness. The relapse rate of alcoholism is
particularly high (75-95%). It has been hypothesized that drug craving is a critical precipitating factor to
relapse and drug craving is influenced by the amount of time abstinent, the exposure to the drug-paired
environment, or drug-paired cues. Convergent data in rodents and humans have indicated that drug-paired
environment or drug-paired cues' ability to elicit drug-craving intensifies with the passage of time during
early abstinence, which can be referred to as ‘cue incubation of drug craving’. The serotonin (5-HT) system
is thought to play a role in the development of alcohol addiction as well as play an important role in the
control of drug-seeking and sensitivity to drug reward and drug cues. The 5-HT7 receptor has been
researched as a potential therapeutic target for various conditions such as anxiety, depression, neuropathic
pain, Alzheimer’s disease, and drug addiction. The activation of 5-HT7 receptors can regulate ‘behavior
control,’ drug-withdrawal symptoms, and cognitive behaviors. However, there is a gap in knowledge of the
involvement of the 5-HT7 receptor in mediating alcohol (EtOH)-seeking behaviors. Extensive preliminary
data conducted in our laboratory have indicated that the systemic and site-specific, specifically in the
nucleus accumbens shell (AcbSh), pharmacological manipulation of 5-HT7 receptor bidirectionally mediates
context- and cue-induced EtOH-seeking. There is a critical need for therapeutic treatments for EtOH-
seeking behaviors and we propose that the 5-HT7 receptors need to be further researched as potential
targets for treatments of alcohol ‘craving’ behaviors. Understanding 5-HT7 mechanisms contributing to the
‘incubation’ of cue-induced EtOH-seeking is very important for developing strategies to reduce or prevent
relapse. The Pavlovian Spontaneous Recovery (PSR) model of EtOH seeking, pharmacological techniques,
and viral vectors will be used to examine the temporal effects of ‘incubation’ of cue-induced EtOH-seeking
behaviors and determine 5-HT7 receptors' involvement in regulating these behaviors. Western blot
techniques will be used to examine cellular mechanisms in ‘behavioral control’ neural circuitry and the
alterations of 5-HT7 receptors expression. Microdialysis and pharmacological techniques will be used to
examine the involvement of 5-HT7 receptors' effects on DA and 5-HT release within the AcbSh associated
with temporal aspects of ‘incubation’ of cue-induced EtOH-seeking. Therefore, we propose to test the
hypothesis that 5-HT7 receptors mediate the incubation’ of cue-induced EtOH-seeking during abstinence by
regulating extracellular levels of DA and 5-HT in the AcbSh and that this response is mediated by the
regulation of 5HT7 receptor expression in the AcbSh dorsal raphe circuit.
摘要:
毒瘾可以被描述为一种慢性反复发作的疾病。酒精中毒的复发率是
特别高(75%-95%)。据推测,对毒品的渴望是一个关键的诱发因素
复发和对毒品的渴求受戒毒时间长短、与毒品配对接触的影响
环境,或毒品配对的线索。在啮齿动物和人类中的趋同数据表明,药物配对
环境或药物配对线索引发药物渴求的能力随着时间的推移而增强
早期戒毒,可称为“线索孕育的药物渴求”。5-羟色胺(5-HT)系统
被认为在酒精成瘾的发展过程中起着重要作用,并在
控制毒品寻觅和对毒品奖励和毒品线索的敏感性。5-HT7受体已经被
被研究为治疗各种疾病的潜在靶点,如焦虑、抑郁、神经病
疼痛、阿尔茨海默氏症和毒瘾。5-HT7受体的激活可以调节人的行为
控制、戒毒症状和认知行为。然而,对这一问题的认识存在差距。
5-HT7受体参与调节酒精(Etoh)寻求行为。广泛的初步
我们实验室进行的数据表明,系统性和特定地点的,特别是在
伏隔核壳蛋白(AcbSh)对5-HT7受体的双向调节作用
语境和线索诱导的乙醇寻找。Etoh的治疗非常需要--
寻找行为,我们认为5-HT7受体作为潜在的可能需要进一步研究
酒精“渴求”行为的治疗目标。了解5-HT7机制
线索诱导的乙醇寻找的‘孵化’对于制定减少或预防的策略非常重要
旧病复发。寻找乙醇的巴甫洛夫自发恢复(PSR)模型,药理学技术,
病毒载体将被用来检测线索诱导的乙醇寻找的时间效应
并确定5-HT7受体参与调节这些行为。蛋白质印迹
技术将被用来检查‘行为控制’神经回路中的细胞机制,以及
5-HT7受体表达的变化。将使用微透析和药理学技术来
探讨5-HT7受体对AcbSh相关脑区DA和5-HT释放的影响
与线索诱导的乙醇寻找的“孵化”有关的时间方面。因此,我们建议测试
5-HT7受体介导线索诱导的酒精戒断潜伏期假说
调节AcbSh细胞外多巴胺和5-羟色胺的水平,这种反应是由
AcbSh背侧中缝环路5HT7受体表达的调节
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sheketha Renay Hauser其他文献
Sheketha Renay Hauser的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sheketha Renay Hauser', 18)}}的其他基金
Adolescent Oxycodone Exposure on Oxycodone Reinforcement and Reward Neurocircuitry in Adulthood
青少年羟考酮暴露对成年期羟考酮强化和奖励神经回路的影响
- 批准号:
10285458 - 财政年份:2021
- 资助金额:
$ 49.46万 - 项目类别:
Adolescent Oxycodone Exposure on Oxycodone Reinforcement and Reward Neurocircuitry in Adulthood
青少年羟考酮暴露对成年期羟考酮强化和奖励神经回路的影响
- 批准号:
10447174 - 财政年份:2021
- 资助金额:
$ 49.46万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 49.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 49.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 49.46万 - 项目类别:














{{item.name}}会员




